Further mechanism studies have shown that HERC3 regulates the TGF-β/Smad2/3 signal through ubiquitination and proteasomal degradation EIF5A2, thereby inhibiting the epithelial–mesenchymal transition (EMT) of CRC [70]. This evidence concerns the gene HERC3 and colorectal carcinoma.